This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
5 of the Best Blue-Chip Dividend Stocks to Buy in October
by Tirthankar Chakraborty
A blue-chip stock has large capitalization, strong balance sheet, solid cash flow and returns a record amount of money to shareholders in the form of dividends
Mednax (MD) Acquires Urology Unit, Deepens Reach in Florida
by Zacks Equity Research
Mednax (MD) continues with inorganic growth at a time when organic growth seems difficult to achieve.
4 Top Performers From Health Insurance Industry in Q3
by Zacks Equity Research
The Health Insurance industry gains from growing medicare business, benefits of ACA, business diversification and healthy balance sheets.
LifePoint (LPNT) Sells Unit to Focus on High-Growth Markets
by Zacks Equity Research
LifePoint (LPNT) continues its inorganic growth via divestitures and acquisitions.
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Centene, Magellan Health and WellCare HealthPlans
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Centene, Magellan Health and WellCare HealthPlans
Anthem Grows on Membership, Public Exchange Woes Hurt
by Zacks Equity Research
Although Anthem's (ANTM) revenue base continues to strengthen on the back of growing membership. Losses incurred in the public exchange business bother.
Zacks Industry Outlook Highlights: Triple-S Management, Anthem, UnitedHealth Group and Select Medical Holdings
by Zacks Equity Research
Zacks Industry Outlook Highlights: Triple-S Management, Anthem, UnitedHealth Group and Select Medical Holdings
Demographic Changes, Diversification Aid Health Insurers
by Zacks Equity Research
Revenues from the managed-care plans of Medicare Advantage are expected to grow significantly as baby boomers retire.
Health Insurance Industry Stock Outlook - Sept. 2017
by Zacks Equity Research
Investing in growing health services business, product diversification, instituting changes in an effort to become more consumer-centric, and investments in technology have helped these companies reap hidden opportunities.
5 Reasons Why You Should Add UnitedHealth to Your Portfolio
by Zacks Equity Research
Solid operating performance, a robust business model, immunity to regulatory uncertainty and a strong earnings outlook make the stock of UnitedHealth (UNH) an attractive one.
Health Care Stocks in Focus as Repeal & Replace Gains Steam
by Zacks Equity Research
Healthcare stocks are jittery due to the regulatory uncertainty that the Graham-Cassidy bill may bring along.
Public Exchange Woes Hit Health Insurers: Stocks in Focus
by Zacks Equity Research
The U.S private health insurers have been incurring mounting losses from the health insurance marketplace. This has led many of them to pull back participation, worsening the scenario for underprivileged Americans.
Inovalon Holdings' ONE Platform Chosen by UnitedHealthcare
by Zacks Equity Research
Inovalon Holding (INOV) will be able to expand in the population health management space through the selection of its proprietary ONE Platform by UnitedHealthcare.
UnitedHealth (UNH) Scales a 52-Week High on Recent Deals
by Zacks Equity Research
UnitedHealth's (UNH) shares are riding on its recent acquisition announcements.
Cigna Shares (CI) Up 38% This Year: Is Further Upside Left?
by Zacks Equity Research
A mix of factors, ranging from industry to company-specific, are favoring the stock of Cigna (CI), driving solid returns.
UnitedHealth to Buy Advisory Board's Health Care Business
by Zacks Equity Research
The acquisition of Advisory Board's health care business will bolster UnitedHealth's (UNH) health management business.
Humana (HUM) Hits 52-Week High on Solid Q2, Raised Outlook
by Zacks Equity Research
Humana's (HUM) shares have been favored by its strong earnings performance, guidance raise and completion of accelerated share buyback.
UnitedHealth (UNH) Up 2.4% Since Earnings Report: Can It Continue?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UnitedHealth Appoints New CEO, Hemsley Takes On New Role
by Zacks Equity Research
UnitedHealth (UNH) promotes internal candidate to the role of new CEO. Current CEO assumes new responsibility.
Envision Healthcare (EVHC) Q2 Earnings Beat, '17 View Cut
by Zacks Equity Research
Envision Healthcare's (EVHC) strong second-quarter earnings were driven by revenue growth in the Physician Services segment, partly offset by an increase in operating expenses.
Select Medical (SEM) Q2 Earnings Top Estimates, Revises View
by Zacks Equity Research
Select Medical's (SEM) solid Q2 results were driven by the strong performance of all segments.
WellCare Health (WCG) Beats on Q2 Earnings and Revenues
by Zacks Equity Research
Wellcare Health (WCG) reported strong results in the second quarter supported by solid performance across its all three business lines and the acquisitions of Universal American and Care1st Arizona
The Ensign Group (ENSG) Q2 Earnings Miss Estimates, Up Y/Y
by Zacks Equity Research
The Ensign Group's (ENSG) second-quarter earnings missed expectations owing to higher expenses.
Aetna (AET) Tops Q2 Earnings, Revenues, Raises 2017 Guidance
by Zacks Equity Research
Aetna's (AET) strong second-quarter 2017 results were largely driven by improved expense ratio.
Teladoc (TDOC) Q2 Loss Wider than Expected, Revenues Up Y/Y
by Zacks Equity Research
Teladoc's (TDOC) second-quarter loss was wider than expected due to higher expenses.